Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05525663 · ClinicalTrials.gov registry record · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
A NA study of Heart Failure With Preserved Ejection Fraction, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 880
- Enrollment target
- 1
- Study location
NCT05525663: Recruiting NA study of Heart Failure With Preserved Ejection Fraction, sponsored by Wake Forest University Health Sciences.
NCT05525663 is a NA study of Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 880 participants, below the 2,267-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05525663, a NA study of Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 880 participants
- Enrollment target
- 1
- Study location
Study Summary
The REHAB-HFpEF trial will determine whether a novel physical rehabilitation intervention will improve the primary outcome of combined all-cause rehospitalizations and mortality and the secondary outcome of major mobility disability during 6-month follow-up in patients hospitalized for heart failure and preserved ejection fraction (HFpEF), which is nearly unique to older persons, and for which there are few treatment options.
Primary Outcome
Rate of combined all-cause rehospitalizations and death 6 months following discharge from index hospitalization.
Conditions Studied
Interventions
- BEHAVIORAL Rehabilitation Intervention
Study Locations (1)
North Carolina
- Atrium Health Wake Forest Baptist - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 880 participants |
| Start Date | 2023-02-16 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT05525663 shows while recruiting
NCT05525663 is an interventional study that assigns participants to a tested intervention. The registered 880 participants enrollment target is mid-sized for trials with a published cap, below the 2,267-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Rehabilitation Intervention is the first listed.
NCT05525663 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05525663 about?
NCT05525663 is a clinical study titled "Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction". The REHAB-HFpEF trial will determine whether a novel physical rehabilitation intervention will improve the primary outcome of combined all-cause rehospitalizations and mortality and the secondary outcome of major mobility disability during 6-month follow-up in patients hospitalized for heart failure...
What is the current status of trial NCT05525663?
This trial is currently recruiting. It is a NA study. The enrollment target is 880 participants. The study started on 2023-02-16. Estimated completion is 2028-01.
What conditions does trial NCT05525663 study?
This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction.
What interventions are being tested in trial NCT05525663?
The interventions under investigation include: Rehabilitation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05525663?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05525663 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Preserved Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05525663's enrollment target sits among peer trials
880 7th of 42 higher than 36 of 42 other Heart Failure With Preserved Ejection Fraction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure With Preserved Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITING · NA
-
Ketogenic Diet vs Mixed Diet in Patients With Heart Failure
RECRUITING · NA
-
Pilot Study Lp299v Supplementation in Chronic Heart Failure
RECRUITING · NA
-
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
RECRUITING · NA
-
Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
RECRUITING · NA
-
Transitions of Care Clinic (TOCC)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT06580314 · 880 participants · Phase 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- NCT06624202 · 880 participants · NA
COmmunities Aligned to Reduce Concussion and Head Impact Exposure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI